Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Year Round Proton Radiation Therapy At PSI Using A New, Dedicated Cyclotron

26.09.2007
A pioneer in proton therapy for the treatment of cancer, PSI has recently introduced one of the most advanced technologies in the field.

A new proton accelerator, a superconducting cyclotron, has been put into operation for patient treatment. The accelerator is used in conjunction with a gantry, a device which delivers the protons to the patient from any angle. The desired dose distribution is achieved by scanning a small pencil beam of protons throughout the tumor. The performance of the new accelerator has been excellent since the start of medical operation.

Proton radiation therapy for deep seated tumors using a compact gantry with spot scanning technology was PSI’s unique contribution to particle radiotherapy worldwide. After 10 years of medical operation (over 260 patients were treated between 1996 and 2005) with PSI’s main accelerator as the beam source, we installed a dedicated proton accelerator for medical use. This relieved the medical program from yearly technical accelerator shut downs of several months and from limited beam availability per day and week, all of which were due to the complexity of a large research facility.

The dedicated proton accelerator (called the COMET) is a compact, superconducting 250 MeV cyclotron. The original design came from the National Superconducting Cyclotron Laboratory at Michigan State University and was adapted to PSI’s specifications and requirements. They included reliable all year round beam production for clinical operation of both the original gantry (Gantry 1) and the eye treatment facility as well as technical flexibilities to accommodate the next generation gantry which features advanced beam scanning and is presently under construction (Gantry 2). Gantry 2 is a further PSI development which will bring beam scanning to the forefront of the medical use of protons.

The cyclotron was fabricated by ACCEL Instruments GmbH (Varian) in Bergisch Gladbach, Germany, and was successfully installed, commissioned and connected to Gantry 1 in 2006/7. The collaboration between ACCEL and PSI resulted in a system that meets stringent specifications, including reliability and efficient maintenance. The technical performance of the cyclotron has met all expectations and the first patient was treated with Gantry 1 and COMET in February 2007. After a planned shut down for technical fine tuning between June and early August patient treatments have been resumed. Future medical operation will be year round.

Gantry 2, with advanced beam scanning and features allowing the treatment of moving targets, will be commissioned in 2008. It is anticipated that the sophisticated technology of COMET and Gantry 2 will determine the future state-of-the-art of proton radiation therapy. Technology transfer to industry and clinics who are interested in advanced proton therapy facilities is foreseen.

Martin Jermann | alfa
Further information:
http://www.psi.ch

More articles from Medical Engineering:

nachricht MRI technique differentiates benign breast lesions from malignancies
20.02.2018 | Radiological Society of North America

nachricht True to type: From human biopsy to complex gut physiology on a chip
14.02.2018 | Wyss Institute for Biologically Inspired Engineering at Harvard

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

'Lipid asymmetry' plays key role in activating immune cells

20.02.2018 | Life Sciences

MRI technique differentiates benign breast lesions from malignancies

20.02.2018 | Medical Engineering

Major discovery in controlling quantum states of single atoms

20.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>